Loading...
Loading...
By Hector Barillas - Thu, 09/10/2026 - 05:30
Mexico's GLP-1 expansion requires parallel diagnostic testing to track cardiometabolic outcomes effectively, writes Héctor Barillas.
https://mexicobusiness.news/tag/obesity
More Health
By Sergio Arturo Lievano Madrigal - Thu, 07/16/2026 - 09:22
PAHO and OAS unveil new school health guidelines and officials push for policy action, as Mexico City hosts the International Congress on Obesity.
By Gustavo Rodríguez Leal - Wed, 07/08/2026 - 08:30
Mexico’s precision medicine must target the gut microbiome to prevent chronic diseases like obesity and diabetes, writes Gustavo Rodríguez.
By Sergio Arturo Lievano Madrigal - Fri, 05/22/2026 - 15:20
New research and pharmaceutical initiatives are pushing GLP-1 therapies beyond obesity treatment and deeper into healthcare systems.
By MBN Staff - Mon, 03/30/2026 - 06:29
PepsiCo launched Doritos Protein, marking a strategic shift toward functional foods.
By Aura Moreno - Fri, 03/20/2026 - 18:06
Phase 3 trials show semaglutide failed to slow early Alzheimer’s, despite biomarker effects, potentially narrowing its role to metabolic care.
By Sofía Garduño - Thu, 03/12/2026 - 10:46
Biotech advances in mRNA, Mexico’s obesity strategy and rising AI use in health highlight this week’s key developments in public health.
By Sofía Garduño - Thu, 03/05/2026 - 11:48
Mexico unveils a national strategy to slow obesity through research, regulation, and prevention with a long-term public health focus.
By Eliza Galeana - Wed, 03/04/2026 - 16:02
The Coca-Cola Company announced a US$6 billion investment in Mexico Meanwhile, hunger in Latin America fell for the fourth consecutive year.
By Eliza Galeana - Mon, 03/02/2026 - 18:17
Hunger in Latin America fell for the fourth consecutive year, yet millions still cannot afford a healthy diet.
By Aura Moreno - Mon, 03/02/2026 - 08:50
Lilly’s oral GLP-1 orforglipron surpassed semaglutide in A1C reduction and weight loss, reshaping the oral cardiometabolic market.
